Jane Gross
Vermogen: 5 538 $ op 31-05-2026
Vermogen: 5 538 $ op 31-05-2026
Jane A. Gross currently works at aTyr Pharma, Inc., as Independent Director from 2019, Life Science Washington, as Director, BriaCell Therapeutics Corp., as Independent Director from 2022, and BriaPro Therapeutics Corp., as Independent Director.
Dr. Gross also formerly worked at ZymoGenetics, Inc., as Vice President-Immunology Research from 2009 to 2010, Emergent BioSolutions, Inc., as VP-Applied Research & Non-Clinical Development from 2011 to 2016, and Aptevo Therapeutics, Inc., as Chief Scientific Officer & Senior Vice President from 2016 to 2021.
Dr. Gross received her doctorate degree in 1990 from the University of California, Berkeley.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ATYR PHARMA, INC. 0,01% | 11-05-2026 | 9.750 ( 0,01% ) | 5 294 $ | 31-05-2026 |
| 28-01-2026 | 66 ( 0% ) | 240 $ | 31-05-2026 | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic products 0,5% | 01-04-2026 | 359.000 ( 0,5% ) | 4 $ | 31-03-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ATYR PHARMA, INC. | Directeur/Bestuurslid | 28-06-2019 |
| BRIACELL THERAPEUTICS CORP. | Directeur/Bestuurslid | 18-01-2022 |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Directeur/Bestuurslid | - |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic products | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 14-09-2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01-08-2016 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | 01-06-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
Aptevo Therapeutics, Inc.
Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau